Orchard Therapeutics PLC (NASDAQ:ORTX)
| 2.03 Delayed Data As of Oct 21 |  -0.04 / -1.92%Today’s Change | 2.00 Today|||52-Week Range 9.08 | -53.01% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2016 | 2017 | 2018 | -- | |||
| Revenue and Income | Net Revenues | 0.00 | 0.00 | 2.1M | -- | |
| Cost of Goods Sold | 0.00 | 0.00 | 421.3K | -- | ||
| Depreciation And Amortization | 6.0K | 305.2K | 1.2M | -- | ||
| Operating Expenses | Gross Income | -6.0K | -305.2K | 454.2K | -- | |
| General Expenses | 19.1M | 38.6M | 235.1M | -- | ||
| Research And Development | 16.2M | 32.9M | 205.0M | -- | ||
| Total Operating Expenses | 19.2M | 38.9M | 236.7M | -- | ||
| Non-Operating Expenses | Operating Income | -19.2M | -38.9M | -234.6M | -- | |
| Extraordinary Credit | 288.2K | 0.00 | 0.00 | -- | ||
| Other Expenses | -153.6K | -1.2M | 4.4M | -- | ||
| Income Taxes, Minority Interest and Extra Items | Pre-Tax Income | -19.0M | -40.1M | -229.1M | -- | |
| Income Taxes | -19.9K | -53.6K | -968.4K | -- | ||
| Net Income | -19.0M | -40.2M | -230.1M | -- | ||
| Shares To Calculate EPS | Shares To Calculate EPS | 8.9M | 11.1M | 22.6M | -- | |
| Shares To Calculate EPS Diluted | 8.9M | 11.1M | 22.6M | -- | ||
| Earnings Per Share | EPS | -$2.14 | -$3.62 | -$10.20 | -- | |
| EPS Diluted | -$2.14 | -$3.62 | -$10.20 | -- | ||
